Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.

Benzer Materyaller

• Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.
  Yazar:: Jennifer Papuchon, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-01-01)
• Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
  Yazar:: Camille Tumiotto, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-01-01)
• Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.
  Yazar:: Jennifer Papuchon, ve diğerleri
  Baskı/Yayın Bilgisi: (2013-01-01)
• ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)
  Yazar:: Hervé Fleury, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-11-01)
• Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).
  Yazar:: Estibaliz Lazaro, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-01-01)